Scholarly Index
Abhishek Maiti
The University of Texas MD Anderson Cancer Center; 4,000 total citations; 327 total publications; best world rank #45
The University of Texas MD Anderson Cancer Center
4,000Total citations
327Total publications
33H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 926 | US 363 | 94.01 |
| Acute Myeloid Leukemia Research | 2021-2025 | 45 | US 33 | 99.51 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 113 | US 72 | 98.05 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 110 | US 61 | 97.97 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 85 | US 40 | 94.51 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 131 | US 77 | 96.64 |
| CAR-T cell therapy research | 2021-2025 | 986 | US 522 | 94.55 |
| Protein Degradation and Inhibitors | 2021-2025 | 443 | US 201 | 91.48 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 877 | US 357 | 91.73 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 647 | US 298 | 91.56 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 563 | US 247 | 91.05 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 118 | US 48 | 84.47 |
| Neutropenia and Cancer Infections | 2021-2025 | 482 | US 170 | 77.68 |